Alzamend Neuro, Inc. ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

First of five Phase 2 trials for AL001 begins in healthy subjects with topline data expected by end of 2025. Preclinical data showed AL001 improved brain absorption with lower blood lithium levels ...

Vicora, a startup that’s working on a catheter system for the treatment of vascular disease such as pulmonary embolisms, deep vein thrombosis and stroke, recently raised a $3.6 million funding round.

Buffalo-based Vicora secures millions in funding to continue development of a new catheter system for treating vascular diseases. C-Level Executive Awards 2025 We're looking for world class ...

KINGSTON, Jamaica — The South East Regional Health Authority (SERHA) is calling for an end to the “politicisation” of the procurement of a $31 million neurosurgical drill for the Bustamante ...

READ: Medical Technologies Limited rejects ‘false statements’ by Dawes over $31m neuro drill However, Dr Dawes said whether or not the serial numbers match, there are follow-up questions that ...

The Louisiana development, named Project Cypress, aims to use federal funds to build carbon removal facilities and a pipeline network that would pull 1 million tons of heat-trapping carbon dioxide ...

As strokes remain a leading cause of death and long-term disability worldwide, the demand for effective clot removal techniques is growing steadily. This, in turn, is accelerating investments in ...

The ALGO Smart Pump showed consistent performance across a range of catheters and offers a compelling, modern alternative for clinicians focused on maximizing clot removal during the first pass.” ...

It now reads: No Director may be removed from the Board by any person or authority, including the President of the United States, without a two-thirds vote of the other Directors confirming such ...